NewAmsterdam Pharma Co. NV (NAMS)
34.37
-1.43
(-3.99%)
USD |
NASDAQ |
Jan 09, 16:00
34.40
+0.03
(+0.09%)
After-Hours: 20:00
NewAmsterdam Pharma Profit Margin (Quarterly): -20.69K% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| uniQure NV | -2.18K% |
| ProQR Therapeutics NV | -381.9% |
| Merus NV (DELISTED) | -786.2% |
| argenx SE | -- |
| Pharming Group NV | 7.71% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -32.32% |
| Return on Assets | -29.68% |
| Return on Invested Capital | -32.30% |
| Gross Profit Margin (Quarterly) | 81.61% |
| Operating Margin (Quarterly) | -15.85K% |
| Return on Net Operating Assets | -2.23K% |